(Total Views: 276)
Posted On: 09/10/2019 9:22:00 AM
Post# of 36568
From SA:
Generex Biotechnology (OTCQB:GNBT) has signed letters of intent with Arizona Endocrinology Center and Paradise Valley Family Medicine to establish NuGenerex Health, LLC, a management services organization (MSO) focused on the delivery and management of healthcare services for patients with chronic, complex medical conditions, particularly diabetes.
Under the terms of the agreements, Generex Biotechnology will establish NuGenerex Health as a multispecialty health services provider that provides ancillary healthcare services and disease management solutions for patients living with chronic medical conditions.
NuGenerex Health is designed as an MSO partnership with the medical groups to offer ophthalmology, podiatry and ancillary health services.
Generex Biotechnology (OTCQB:GNBT) has signed letters of intent with Arizona Endocrinology Center and Paradise Valley Family Medicine to establish NuGenerex Health, LLC, a management services organization (MSO) focused on the delivery and management of healthcare services for patients with chronic, complex medical conditions, particularly diabetes.
Under the terms of the agreements, Generex Biotechnology will establish NuGenerex Health as a multispecialty health services provider that provides ancillary healthcare services and disease management solutions for patients living with chronic medical conditions.
NuGenerex Health is designed as an MSO partnership with the medical groups to offer ophthalmology, podiatry and ancillary health services.
(0)
(0)
